Military

Military

DARPA

DARPA has several ongoing programs focused of COVID-19 medical countermeasures. Several active programs are engaged in research of rapid detection of COVID-19 exposure or infection in both symptomatic and asymptomatic individuals: Epigenetic CHaracterization and Observation (ECHO), Prometheus, Friend or Foe, SIGMA+ and PREPARE. In addition, DARPA provided some funding support to Sherlock Biosciences, which is developing CRISPR SARS-CoV-2 kit for rapid detection of the virus, providing results in approximately one hour.

More at: https://www.darpa.mil/work-with-us/covid-19